Sreetama Dutt is a news curator and columnist at Rheumatoid Arthritis News. She studied biotechnology at SRM Institute of Science and Technology, and did her Masters in medical microbiology at University of Manchester in Manchester, UK.
Tabalumab, an anti-B Cell Activating Factor (BAFF) monoclonal antibody, which has been designed to treat autoimmune disorders and B-cell malignancies, by Eli Lilly and Company, did not meet its primary ... Read more
Patients with Rheumatoid Arthritis (RA) are prone to develop fibromyalgia symptoms, according to recently conducted research presented presented by Perebetyuk L, et al, during the European League Against Rheumatism Annual European Congress of ... Read more
Rheumatoid Arthritis is a growing medical concern in the United States, with over 1.5 million adults affected by the disease annually. With RA, the immune system overreacts, attacking the patient’s joints and their ... Read more
Recent research has shown patients with newly presented, symmetric rheumatoid arthritis and those with the chikungunya virus (CHIKV) displayed similar characteristics in terms of presentation of immune cells and clinical ... Read more
Researchers agree that interactions between cell membrane proteins and sugars hold the key to understanding the molecular basis of many diseases. Sugar molecules, which are attached to cell membranes like an antennae, ... Read more
Analysis of pregnant women’s health and their subsequent effects on fetal health was recently performed on data obtained by the Organization of Teratology Information Specialists (OTIS), a North American university and hospital-based ... Read more